Participants in a new study who used GLP-1 drugs had a much lower cancer risk than those who had bariatric surgery.

Polycystic ovary syndrome (PCOS) is a complex hormonal condition affecting an estimated eight to 20 percent of women of ...

Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...

Improvements with GLP-1 RAs in psoriasis and other chronic skin diseases point to their increased use in dermatology and a ...

As the popularity of weight-loss drugs constantly increases, new discoveries about their impact is coming out. Research has ...

Weight loss injections may have a powerful anti-cancer effect, new research suggests. Experts already know that losing weight ...

New research suggests that weight loss injections may not only help people lose weight but could also reduce the risk of ...

Learn about SYNT-101, the emerging treatment for obesity that combines the best of two proven methods.

The analysis of 11 weight-loss drug studies by the University of Oxford found that patients typically lost 8kg (18lb) after ...

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...

Social media users have shared their hair loss experience when taking weight loss medications such as Ozempic. Here, a doctor ...

New research suggests that weight loss injections, also known as GLP-1 receptor agonists, may have a significant anti-cancer ...